Are sites of primary lesions in pemphigus vulgaris more prone to relapse?
Oral Diseases · 2024
DOI: 10.1111/odi.14872 ↗Kurz gefasst
Leserbrief in der Zeitschrift Oral Diseases, 2024. Verfasst von Ali Mohammadi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Pemphigus, Recurrence. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Blood Transfusion Research Center, High Institute for Research and Education, Tehran, Iran.
ORCID-Profile: Moojan Forouzandegan, Kamran Balighi, Maryam Daneshpazhooh
Zitieren
APA
Mohammadi, A., Forouzandegan, M., Mahmoudi, H., Teimourpour, A., Balighi, K., & Daneshpazhooh, M. (2024). Are sites of primary lesions in pemphigus vulgaris more prone to relapse?. Oral Diseases. https://doi.org/10.1111/odi.14872
Vancouver
Mohammadi A, Forouzandegan M, Mahmoudi H, Teimourpour A, Balighi K, Daneshpazhooh M. Are sites of primary lesions in pemphigus vulgaris more prone to relapse?. Oral Diseases. 2024. doi:10.1111/odi.14872
BibTeX
@article{Mohammadi2024,
author = {Mohammadi, Ali and Forouzandegan, Moojan and Mahmoudi, Hamidreza and Teimourpour, Amir and Balighi, Kamran and Daneshpazhooh, Maryam},
title = {Are sites of primary lesions in pemphigus vulgaris more prone to relapse?},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14872}
}
EUVIMED